KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Accumulated Expenses (2018 - 2025)

ClearPoint Neuro (CLPT) has disclosed Accumulated Expenses for 13 consecutive years, with $4.4 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses fell 10.75% to $4.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.4 million through Dec 2025, down 10.75% year-over-year, with the annual reading at $4.4 million for FY2025, 10.75% down from the prior year.
  • Accumulated Expenses hit $4.4 million in Q4 2025 for ClearPoint Neuro, up from $3.5 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $4.9 million in Q4 2024 to a low of $990000.0 in Q1 2021.
  • Historically, Accumulated Expenses has averaged $2.5 million across 5 years, with a median of $2.3 million in 2023.
  • Biggest five-year swings in Accumulated Expenses: soared 65.76% in 2024 and later decreased 10.75% in 2025.
  • Year by year, Accumulated Expenses stood at $2.6 million in 2021, then rose by 8.45% to $2.8 million in 2022, then grew by 4.36% to $2.9 million in 2023, then surged by 65.76% to $4.9 million in 2024, then fell by 10.75% to $4.4 million in 2025.
  • Business Quant data shows Accumulated Expenses for CLPT at $4.4 million in Q4 2025, $3.5 million in Q3 2025, and $2.9 million in Q2 2025.